A detailed history of Castleark Management LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 1,040 shares of MEDP stock, worth $348,618. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,040
Previous 24,570 95.77%
Holding current value
$348,618
Previous $10.1 Million 96.58%
% of portfolio
0.01%
Previous 0.42%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$320.58 - $457.29 $7.54 Million - $10.8 Million
-23,530 Reduced 95.77%
1,040 $346,000
Q2 2024

Aug 13, 2024

SELL
$372.0 - $424.34 $78,120 - $89,111
-210 Reduced 0.85%
24,570 $10.1 Million
Q1 2024

May 15, 2024

SELL
$284.87 - $413.31 $948,617 - $1.38 Million
-3,330 Reduced 11.85%
24,780 $10 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $530,121 - $728,544
2,330 Added 9.04%
28,110 $8.62 Million
Q3 2023

Nov 15, 2023

BUY
$233.98 - $281.67 $3.23 Million - $3.89 Million
13,800 Added 115.19%
25,780 $6.24 Million
Q2 2023

Aug 15, 2023

SELL
$187.26 - $240.17 $20,598 - $26,418
-110 Reduced 0.91%
11,980 $2.88 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $2.11 Million - $2.9 Million
12,090 New
12,090 $2.27 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $6.19 Million - $9.55 Million
-44,540 Closed
0 $0
Q4 2021

Feb 16, 2022

BUY
$182.74 - $227.9 $8.14 Million - $10.2 Million
44,540 New
44,540 $9.69 Million
Q1 2021

May 14, 2021

SELL
$132.02 - $168.26 $6.64 Million - $8.46 Million
-50,276 Closed
0 $0
Q4 2020

Feb 17, 2021

SELL
$109.38 - $149.19 $4.13 Million - $5.63 Million
-37,725 Reduced 42.87%
50,276 $7 Million
Q3 2020

Nov 16, 2020

BUY
$92.95 - $130.61 $8.18 Million - $11.5 Million
88,001 New
88,001 $9.83 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.